BioInvent International AB
BioInvent International AB's Overview
BioInvent International AB is a Swedish clinical-stage biotechnology company focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies for cancer therapy. The company leverages its proprietary F.I.R.S.T™ technology platform to identify and characterize target structures and antibody candidates. BioInvent has a broad pipeline of proprietary and partnered programs, aiming to significantly improve the efficacy of current cancer treatments and the quality of life for patients. Their research targets various mechanisms within the tumor microenvironment to activate the immune system against cancer cells.
Where is BioInvent International AB's Headquarters?
HQ Function
The Lund headquarters serves as the central hub for research and development, clinical operations management, corporate administration, and strategic decision-making.
Notable Features:
Located within Medicon Village Science Park, providing access to state-of-the-art laboratories, collaborative research facilities, and a vibrant biotech ecosystem.
Work Culture:
The work culture at BioInvent likely emphasizes scientific rigor, innovation, collaboration, and a strong focus on translational research to bring new cancer therapies to patients.
HQ Significance:
The headquarters is pivotal for BioInvent's operations, driving its antibody discovery engine and managing its global clinical trial programs.
Values Reflected in HQ: The headquarters' location and facilities reflect BioInvent's commitment to cutting-edge science, innovation, and collaboration within the life sciences community.
Location:
While headquartered in Sweden, BioInvent International AB has a global presence through its clinical trial operations conducted in multiple countries across North America, Europe, and potentially other regions. They collaborate with international research institutions, clinical sites, and pharmaceutical partners to advance their pipeline of immuno-oncology candidates.
Street Address:
Sölvegatan 41
City:
Lund
State/Province:
Skåne County
Country:
Sweden
BioInvent International AB's Global Presence
Buying Intent Signals for BioInvent International AB
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of BioInvent International AB
As of April 2025, BioInvent International AB' leadership includes:
Investors of BioInvent International AB
BioInvent International AB has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In late 2023, BioInvent strengthened its executive team with the appointment of a new Chief Operating Officer. No major executive departures were publicly noted during this period.
New Appointments:
Technology (Tech Stack) used by BioInvent International AB
Discover the tools BioInvent International AB uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BioInvent International AB Email Formats and Examples
BioInvent International AB likely uses common corporate email formats. The most probable format is `firstname.lastname@bioinvent.com`. Other variations might exist but this is a standard convention.
firstname.lastname@bioinvent.com
Format
martin.welschof@bioinvent.com
Example
85%
Success rate
News and media
BioInvent Press Release • May 23, 2024
BioInvent International AB Publishes Interim Report January-March 2024
BioInvent released its Q1 2024 financial results and provided an update on its clinical development programs, highlighting progress in its BI-1808 and BI-1206 trials....more
BioInvent Press Release • April 5, 2024
BioInvent International AB Presents New Preclinical Data on its TNFR2 Program BI-1910 at AACR Annual Meeting 2024
BioInvent presented promising preclinical data for BI-1910, an agonistic anti-TNFR2 antibody, demonstrating its potential as a novel immuno-oncology therapy, at the American Association for Cancer Research (AACR) Annual Meeting....more
BioInvent Press Release • December 1, 2023
BioInvent International AB Appoints Marie Moores as Chief Operating Officer
BioInvent announced the appointment of Marie Moores as its new Chief Operating Officer (COO), effective December 1, 2023, to support the company's growth and operational execution....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including BioInvent International AB, are just a search away.